EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting Interleukin-8–Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome

Jakob Fell, Mario G Pavez-Giani, Fabian Koitka iD, George Kensah iD, Gabriela Leao Santos iD, Emiel P C van der Vorst iD, Christof Lenz iD, Gabriela Salinas iD, Alexandra Victoria Busley, Alisa Fedorenko iD, Robin Hindmarsh, Cordula Maria Wolf iD und 5 weitere

Circulation · 2026

DOI: 10.1161/circulationaha.125.074155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2026. Verfasst von Jakob Fell und 16 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Cardiology and Pneumology (J.F., M.G.P.-G., F.K., A.V.B., A.F., R.H., G.H., L.C.), University Medical Center Göttingen, Göttingen, Ger…. Hauptthemen laut MEDLINE: Interleukin-8, Noonan Syndrome, Cardiomyopathy, Hypertrophic, Myocytes, Cardiac. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Genetic variants in components or regulators of the RAS–mitogen-activated protein kinase (RAS-MAPK) signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome (NS). Despite paracrine communication being considered to play a pivotal role in the etiology of cardiomyopathies, there is a paucity of knowledge about the underlying pathomechanism that leads to the development of HCM and cardiac fibrosis in NS. METHODS: To dissect the impact of noncardiomyocytes in the development of NS, we employed two-dimensional and three-dimensional human induced pluripotent stem cell models of LZTR1 deficiency alongside induced pluripotent stem cells derived from patients with NS with pathogenic variants in key RAS-MAPK genes and analyzed these cells and tissues at the molecular, cellular, and functional levels. RESULTS: Our findings revealed that cytokine-mediated cellular crosstalk between cardiac fibroblasts and cardiomyocytes, predominantly activated in the disease state, serves as a primary driver of the disease. Cardiac fibroblast–specific IL-8 (interleukin-8) secretion induced fibrosis-related signatures, tissue stiffness, cardiomyocyte hypertrophy, and hypercontractility, identifying dysregulated IL-8 as a heart-autonomous signaling molecule independent of inflammation and immune cell involvement. Inhibition of IL-8–CXCR1 signaling by reparixin reversed the pathological effects in cardiac fibroblasts and cardiomyocytes. CONCLUSIONS: These data provide evidence that targeting aberrant IL-8–CXCR1 signaling may be an effective therapeutic option for patients with NS-associated HCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-8Noonan SyndromeCardiomyopathy, HypertrophicMyocytes, CardiacHumansFibrosisInduced Pluripotent Stem CellsFibroblastsCell CommunicationSignal TransductionCells, Cultured

Stichwörter der Autor:innen

Noonan syndromecardiomyocytescytokineshypertrophic cardiomyopathyinduced pluripotent stem cellsinterleukin-8paracrine communication

Substanzen

Interleukin-8CXCL8 protein, human

Autor:innen und Institutionen

  • Departments of Cardiology and Pneumology (J.F., M.G.P.-G., F.K., A.V.B., A.F., R.H., G.H., L.C.), University Medical Center Göttingen, Göttingen, Germany.
  • German Center for Cardiovascular Research, partner site Lower Saxony, Göttingen, Germany (J.F., M.G.P.-G., F.K., G.K., G.L.S., C.L., A.V.B., S.L., G.H., W.-H.Z., B.W., L.C.).
  • Cluster of Excellence "Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells", University of Göttingen, Göttingen, Germany (F.K., C.L., A.V.B., G.H., W.-H.Z., B.W., L.C.).
  • Cardiothoracic and Vascular Surgery (G.K.), University Medical Center Göttingen, Göttingen, Germany.
  • Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland (G.K.).
  • Institute of Pharmacology and Toxicology (G.L.S., S.L., W.-H.Z.), University Medical Center Göttingen, Göttingen, Germany.

ORCID-Profile: Fabian Koitka, George Kensah, Gabriela Leao Santos, Emiel P C van der Vorst, Christof Lenz, Gabriela Salinas, Alisa Fedorenko, Cordula Maria Wolf, Susanne Lutz, Wolfram-Hubertus Zimmermann, Bernd Wollnik, Lukas Cyganek

Zitieren

APA

Fell, J., Pavez-Giani, M. G., Koitka, F., Kensah, G., Santos, G. L., van der Vorst, E. P. C., Lenz, C., Salinas, G., Busley, A. V., Fedorenko, A., Hindmarsh, R., Wolf, C. M., Lutz, S., Hasenfuss, G., Zimmermann, W. H., Wollnik, B., & Cyganek, L. (2026). Targeting Interleukin-8–Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome. Circulation. https://doi.org/10.1161/circulationaha.125.074155

Vancouver

Fell J, Pavez-Giani MG, Koitka F, Kensah G, Santos GL, van der Vorst EPC, et al. Targeting Interleukin-8–Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome. Circulation. 2026. doi:10.1161/circulationaha.125.074155

BibTeX
@article{Fell2026,
  author = {Fell, Jakob and Pavez-Giani, Mario G and Koitka, Fabian and Kensah, George and Santos, Gabriela Leao and van der Vorst, Emiel P C and Lenz, Christof and Salinas, Gabriela and Busley, Alexandra Victoria and Fedorenko, Alisa and Hindmarsh, Robin and Wolf, Cordula Maria and Lutz, Susanne and Hasenfuss, Gerd and Zimmermann, Wolfram-Hubertus and Wollnik, Bernd and Cyganek, Lukas},
  title = {Targeting Interleukin-8–Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome},
  journal = {Circulation},
  year = {2026},
  doi = {10.1161/circulationaha.125.074155}
}
Kostenlos starten →